SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001582629-17-000002
Filing Date
2017-05-15
Accepted
2017-05-15 12:08:54
Documents
1
Period of Report
2017-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 1613
  Complete submission text file 0001582629-17-000002.txt   3309
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1601 BLAKE STREET SUITE 310 DENVER CO 80202
Business Address
Flanigan Conn (Reporting) CIK: 0001582629 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55016 | Film No.: 17842548